These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Lymph node diagnosis with imaging methods. An overview with special reference to recent developments in the area of MR contrast media]. Mohr U; Weissleder R Z Lymphol; 1996 Jun; 20(1):15-20. PubMed ID: 8768044 [TBL] [Abstract][Full Text] [Related]
4. Phase I clinical evaluation of Gd-EOB-DTPA as a hepatobiliary MR contrast agent: safety, pharmacokinetics, and MR imaging. Hamm B; Staks T; Mühler A; Bollow M; Taupitz M; Frenzel T; Wolf KJ; Weinmann HJ; Lange L Radiology; 1995 Jun; 195(3):785-92. PubMed ID: 7754011 [TBL] [Abstract][Full Text] [Related]
5. A new macromolecule as a contrast agent for MR angiography: preparation, properties, and animal studies. Bogdanov AA; Weissleder R; Frank HW; Bogdanova AV; Nossif N; Schaffer BK; Tsai E; Papisov MI; Brady TJ Radiology; 1993 Jun; 187(3):701-6. PubMed ID: 8497616 [TBL] [Abstract][Full Text] [Related]
6. Gadolinium-ethoxybenzyl-DTPA, a new liver-specific magnetic resonance contrast agent. Kinetic and enhancement patterns in normal and cholestatic rats. Clément O; Mühler A; Vexler V; Berthezène Y; Brasch RC Invest Radiol; 1992 Aug; 27(8):612-9. PubMed ID: 1428739 [TBL] [Abstract][Full Text] [Related]
7. Comparison of Gd [DTPA-bis (2-aminoethoxy) ethane] polymeric contrast agent with gadodiamide injection for interstitial MR lymphography: experimental study with rabbits. Zhou Z; Guo J; Yu H; Zhu B; Liu C; Jiang X; Zhang M; Chen J J Magn Reson Imaging; 2005 Sep; 22(3):361-7. PubMed ID: 16106365 [TBL] [Abstract][Full Text] [Related]